Factors influencing local tumor control after Gamma Knife radiosurgery for intracranial metastases from breast cancer

Satoshi Suzuki, Takuya Inoue, Katsuya Ishido

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Because evaluation of Gamma Knife radiosurgery (GKRS) for brain metastases (METs) has mainly been based on overall or progression-free survival rates, that is, patients’ general condition and control of the primary disease, we focused on factors influencing local tumor control after GKRS for METs from breast cancer. Data were retrospectively collected from our institution's records of patients who had undergone GKRS twice or more for METs from breast cancer. Failed GKRS was defined as a tumor needing re-treatment by further GKRS or having already been treated by other modalities prior to later GKRS procedures. Influences of various factors on local tumor control were examined. GKRS was performed on 623 tumors in 123 sessions in 90 patients. Median follow up was 9 months (range 1–41 months). According to multivariate analysis, use of HER2-targeting agents, (hazard ratio [HR] 0.42, 95% confidence interval [CI] 0.18–0.99, p = 0.049), five or more lesions (HR 0.24, 95% CI 0.11–0.51, p < 0.001), volume >1.2 cm3 (HR 3.12, 95% CI 1.62–6.02, p < 0.001), use of GK model B (HR 2.53, 95% CI 1.28–4.98, p = 0.0076), and prescribed dosage ⩾18 Gy (HR 0.19, 95% CI 0.01–0.51, p < 0.001) were predictors of failed GKRS. Patients with METs from breast cancer with HER2-positive tumors, five or more lesions, and tumors of volume ⩽1.2 cm3 are good candidates for GKRS. GK model C and Perfexion achieve better local tumor control than does GK model B. The recommended dosage is ⩾18 Gy.

Original languageEnglish
Pages (from-to)154-158
Number of pages5
JournalJournal of Clinical Neuroscience
Volume33
DOIs
Publication statusPublished - Nov 1 2016
Externally publishedYes

Fingerprint

Radiosurgery
Breast Neoplasms
Neoplasm Metastasis
Neoplasms
Confidence Intervals
Tumor Burden
Proportional Hazards Models
Disease-Free Survival
Multivariate Analysis
Survival Rate
Brain

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology
  • Physiology (medical)

Cite this

Factors influencing local tumor control after Gamma Knife radiosurgery for intracranial metastases from breast cancer. / Suzuki, Satoshi; Inoue, Takuya; Ishido, Katsuya.

In: Journal of Clinical Neuroscience, Vol. 33, 01.11.2016, p. 154-158.

Research output: Contribution to journalArticle

@article{9eddfef6d1614cb0ab5666a96fe0a6c2,
title = "Factors influencing local tumor control after Gamma Knife radiosurgery for intracranial metastases from breast cancer",
abstract = "Because evaluation of Gamma Knife radiosurgery (GKRS) for brain metastases (METs) has mainly been based on overall or progression-free survival rates, that is, patients’ general condition and control of the primary disease, we focused on factors influencing local tumor control after GKRS for METs from breast cancer. Data were retrospectively collected from our institution's records of patients who had undergone GKRS twice or more for METs from breast cancer. Failed GKRS was defined as a tumor needing re-treatment by further GKRS or having already been treated by other modalities prior to later GKRS procedures. Influences of various factors on local tumor control were examined. GKRS was performed on 623 tumors in 123 sessions in 90 patients. Median follow up was 9 months (range 1–41 months). According to multivariate analysis, use of HER2-targeting agents, (hazard ratio [HR] 0.42, 95{\%} confidence interval [CI] 0.18–0.99, p = 0.049), five or more lesions (HR 0.24, 95{\%} CI 0.11–0.51, p < 0.001), volume >1.2 cm3 (HR 3.12, 95{\%} CI 1.62–6.02, p < 0.001), use of GK model B (HR 2.53, 95{\%} CI 1.28–4.98, p = 0.0076), and prescribed dosage ⩾18 Gy (HR 0.19, 95{\%} CI 0.01–0.51, p < 0.001) were predictors of failed GKRS. Patients with METs from breast cancer with HER2-positive tumors, five or more lesions, and tumors of volume ⩽1.2 cm3 are good candidates for GKRS. GK model C and Perfexion achieve better local tumor control than does GK model B. The recommended dosage is ⩾18 Gy.",
author = "Satoshi Suzuki and Takuya Inoue and Katsuya Ishido",
year = "2016",
month = "11",
day = "1",
doi = "10.1016/j.jocn.2016.03.037",
language = "English",
volume = "33",
pages = "154--158",
journal = "Journal of Clinical Neuroscience",
issn = "0967-5868",
publisher = "Churchill Livingstone",

}

TY - JOUR

T1 - Factors influencing local tumor control after Gamma Knife radiosurgery for intracranial metastases from breast cancer

AU - Suzuki, Satoshi

AU - Inoue, Takuya

AU - Ishido, Katsuya

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Because evaluation of Gamma Knife radiosurgery (GKRS) for brain metastases (METs) has mainly been based on overall or progression-free survival rates, that is, patients’ general condition and control of the primary disease, we focused on factors influencing local tumor control after GKRS for METs from breast cancer. Data were retrospectively collected from our institution's records of patients who had undergone GKRS twice or more for METs from breast cancer. Failed GKRS was defined as a tumor needing re-treatment by further GKRS or having already been treated by other modalities prior to later GKRS procedures. Influences of various factors on local tumor control were examined. GKRS was performed on 623 tumors in 123 sessions in 90 patients. Median follow up was 9 months (range 1–41 months). According to multivariate analysis, use of HER2-targeting agents, (hazard ratio [HR] 0.42, 95% confidence interval [CI] 0.18–0.99, p = 0.049), five or more lesions (HR 0.24, 95% CI 0.11–0.51, p < 0.001), volume >1.2 cm3 (HR 3.12, 95% CI 1.62–6.02, p < 0.001), use of GK model B (HR 2.53, 95% CI 1.28–4.98, p = 0.0076), and prescribed dosage ⩾18 Gy (HR 0.19, 95% CI 0.01–0.51, p < 0.001) were predictors of failed GKRS. Patients with METs from breast cancer with HER2-positive tumors, five or more lesions, and tumors of volume ⩽1.2 cm3 are good candidates for GKRS. GK model C and Perfexion achieve better local tumor control than does GK model B. The recommended dosage is ⩾18 Gy.

AB - Because evaluation of Gamma Knife radiosurgery (GKRS) for brain metastases (METs) has mainly been based on overall or progression-free survival rates, that is, patients’ general condition and control of the primary disease, we focused on factors influencing local tumor control after GKRS for METs from breast cancer. Data were retrospectively collected from our institution's records of patients who had undergone GKRS twice or more for METs from breast cancer. Failed GKRS was defined as a tumor needing re-treatment by further GKRS or having already been treated by other modalities prior to later GKRS procedures. Influences of various factors on local tumor control were examined. GKRS was performed on 623 tumors in 123 sessions in 90 patients. Median follow up was 9 months (range 1–41 months). According to multivariate analysis, use of HER2-targeting agents, (hazard ratio [HR] 0.42, 95% confidence interval [CI] 0.18–0.99, p = 0.049), five or more lesions (HR 0.24, 95% CI 0.11–0.51, p < 0.001), volume >1.2 cm3 (HR 3.12, 95% CI 1.62–6.02, p < 0.001), use of GK model B (HR 2.53, 95% CI 1.28–4.98, p = 0.0076), and prescribed dosage ⩾18 Gy (HR 0.19, 95% CI 0.01–0.51, p < 0.001) were predictors of failed GKRS. Patients with METs from breast cancer with HER2-positive tumors, five or more lesions, and tumors of volume ⩽1.2 cm3 are good candidates for GKRS. GK model C and Perfexion achieve better local tumor control than does GK model B. The recommended dosage is ⩾18 Gy.

UR - http://www.scopus.com/inward/record.url?scp=84992405264&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992405264&partnerID=8YFLogxK

U2 - 10.1016/j.jocn.2016.03.037

DO - 10.1016/j.jocn.2016.03.037

M3 - Article

VL - 33

SP - 154

EP - 158

JO - Journal of Clinical Neuroscience

JF - Journal of Clinical Neuroscience

SN - 0967-5868

ER -